dc.relation.reference | 1. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA. 1995; 274(2):131-6.
2. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-1357.
3. LaRosa JC, He J, Vupputuri S: Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282:2340-2346.
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S): Lancet 1994;344:1383-1389.
5. Huikuri HV, Castellanos A, Myerburg RJ: Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
6. Parkes J, Bryant J, Milne R. Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness. Heart. 2002; 87(5):438-42.
7. De Sutter J, Tavernier R, De Buyzere M, Jordaens L, De Backer G. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol. 2000;36:766-772.
8. Mitchell LB, Powell JL, Gillis AM et al: Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the antiarrhythmics versus implantable defibrillators (AVID) trial. J Am Coll Cardiol 2003;42:81-87.
9. Gould KL. Reversal of coronary atherosclerosis. Clinical promise as the basis for noninvasive management of coronary artery disease. Circulation. 1994;90:1558-1571.
10. Charnock JS. Lipids and cardiac arrhythmia. Prog. Lipid Res. 1994; 33(4): 335-385.
11. Paolisso G, Gualdiero P, Manzella D, Rizzo MR, Tagliamonte MR, Gambardella A, Verza M, Gentile S, Varricchio M. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in non-ishemic non-insulin-dependent diabetic patients. Am J Cardiol 1997; 80(7):932-7.
12. Jouven X, Charles MA, Desnos M et al: Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 2001;104:756-761.
13. Oliver MF: Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med 2002;112:305-311.
14. Centers for Disease Control and Prevention: State-specific mortality from sudden cardiac death--United States, 1999. MMWR Morb.Mortal.Wkly.Rep. 2002;51:123-126.
15. Viskin S, Golovner M, Malov N, Fish R, Alroy I, Vila Y, Laniado S, Kaplinsky E, Roth A: Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes. Eur Heart J 1999;20:1429-1434.
16. Peters RW: Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience). Am.J.Cardiol. 1990;66:57G-59G.
17. Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L: Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-330.
18. Sutula T, He X-X, Cavazos J, Grayson S: Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 1988;239:1147-1150.
19. Vracko R, Thorning D, Frederickson RG: Fate of nerve fibers in necrotic, healing, and healed rat myocardium. Lab Invest 1990;63:490-501.
20. Vracko R, Thorning D, Frederickson RG: Nerve fibers in human myocardial scars. Hum Pathol 1991;22:138-146.
21. Chen P-S, Chen LS, Cao JM, Sharifi B, Karagueuzian HS, Fishbein MC: Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res 2001;50:409-416.
22. Cao J-M, Fishbein MC, Han JB, Lai WW, Lai AC, Wu T-J, Czer L, Wolf PL, Denton TA, Shintaku IP, Chen P-S, Chen LS: Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000;101:1960-1969.
23. Cao J-M, Chen LS, KenKnight BH, Ohara T, Lee M-H, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC, Chen P-S: Nerve sprouting and sudden cardiac death. Circ Res 2000;86:816-821.
24. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH: Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-138.
25. Arntz HR, Willich SN, Oeff M, Bruggemann T, Stern R, Heinzmann A, Matenaer B, Schroder R: Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation. Circulation 1993;88:2284-2289.
26. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C: Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994;90:241-247.
27. Wood MA, Simpson PM, London WB, Stambler BS, Herre JM, Bernstein RC, Ellenbogen KA: Circadian pattern of ventricular tachyarrhythmias in patients implantable cardioverter-defibrillators. J Am Coll Cardiol 1995;25:901-907.
28. Aronow WS, Ahn C, Mercando AD, Epstein S: Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1994;74:819-821.
29. Kong JrTQ, Goldberger JJ, Parker M, Wang T, Kadish AH: Circadian variation in human ventricular refractoriness. Circulation 1995;92:1507-1516.
30. Yamashita T, Sekiguchi A, Iwasaki YK, Sagara K, Iinuma H, Hatano S, Fu LT, Watanabe H: Circadian variation of cardiac K+ channel gene expression. Circulation 2003;107:1917-1922.
31. Middlekauff HR, Sontz EM: Morning sympathetic nerve activity is not increased in humans. Implications for mechanisms underlying the circadian pattern of cardiac risk. Circulation 1995;91:2549-2555.
32. Peckova M, Fahrenbruch CE, Cobb LA, Hallstrom AP: Weekly and seasonal variation in the incidence of cardiac arrests. Am.Heart J. 1999;137:512-515.
33. Jardine DL, Charles CJ, Forrester MD, Whitehead M, Nicholls MG: A neural mechanism for sudden death after myocardial infarction. Clin.Auton.Res. 2003;13:339-341.
34. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 1990; 82:1095–1104.
35. Randall WC, Szentivanyi M, Pace JB, Wechsler JS, Kaye MP. Patterns of sympathetic nerve projections onto the canine heart. Circ Res 1968;22:315–323.
36. Guth L. Regeneration in the mammalian peripheral nervous system. Physiol Rev 1956;36:441–478.
37. R. Vracko, D. Thorning and R.G. Frederickson, Nerve fibers in human myocardial scars. Hum Pathol 22 (1991), pp. 138–146.
38. T. Oki, N. Fukuda, T. Kawano et al., Histopathologic studies of innervation of normal and prolapsed human mitral valves. J Heart Valve Dis 4 (1995), pp. 496–502.
39. K. Marron, J. Wharton, M.N. Sheppard et al., Distribution, morphology, and neurochemistry of endocardial and epicardial nerve terminal arborizations in the human heart. Circulation 92 (1995), pp. 2343–2351.
40. S. Gulbenkian, O.O. Saetrum, R. Ekman et al., Peptidergic innervation of human epicardial coronary arteries. Circ Res 73 (1993)
41. L.T. Chow, W.H. Chow, J.C. Lee, S.S. Chow, R.H. Anderson and J.A. Gosling, Postmortem changes in the immunohistochemical demonstration of nerves in human ventricular myocardium. J Anat 192 1 (1998), pp. 73–80.
42. Gill JS, Hunter GJ, Gane J, et al. Asymmetry of cardiac [123I] meta-iodobenzyl- guanidine scans with ventricular tachycardia and a “clinically normal” heart. Br. Heart J. 1993; 69:6-13.
43. Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl. Med. 1981; 22:22-31.
44. Wieland DM, Brown LE, Tobes MC, Rogers WL, Marsh DD, Manger TJ et al. Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzyl- guanidine: concise communication. J Nucl. Med. 1981; 22:358-364.
45. Matheja P, Schafers M, Weckesser M, wichter T, Schober O. Imaging sympathetic innervation. Q J Nucl Med 1999; 43: 281-290.
46. Patel AD and Iskandrian AE. MIBG Imaging. J Nucl Cardiol 2002; 9: 75-94.
47. Terai H, Shimizu M, Ino H, Yamaguchi M, Hayashi K, Sakata K, Kiyama M, Hayashi T, Inoue M, Taki J, Mabuchi H. Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias. J Nucl Cardiol. 2003;10(3):304-10.
48. Wichter T, Matheja P, Eckardt L, Kies P, Schafers K, Schulze-Bahr E, Haverkamp W, Borggrefe M, Schober O, Breithardt G, Schafers M. Cardiac autonomic dysfunction in Brugada syndrome. Circulation. 2002;105(6):702-6.
49. Biffi M, Fallani F, Boriani G, Fanti S, Kowoll L, Pettinato C, Monetti N, Branzi A. Abnormal cardiac innervation in patients with idiopathic ventricular fibrillation. Pacing Clin Electrophysiol. 2003;26(1 Pt 2):357-60.
50. Arora R, Ferrick KJ, Nakata T, Kaplan RC, Rozengarten M, Latif F, Ng K, Marcano V, Heller S, Fisher JD, Travin MI. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003; 10(2):121-31.
51. Simoes MV, Barthel P, Matsunari I, Nekolla SG, Schomig A, Schwaiger M, Schmidt G, Bengel FM. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004 Apr;25(7):551-7.
52. Houle MS, Billman GE. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol. 199;276(1 Pt 2):H215-23.
53. Arai Y, Saul JP, Albrecht P, Hartley LH, Lilly LS, Cohen RJ, Colucci WS. Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol. 1989; 256(1 Pt 2):H132-41.
54. Stauss HM, Mrowka R, Nafz B, Patzak A, Unger T, Persson PB. Does low frequency power of arterial blood pressure reflect sympathetic tone? J Auton Nerv Syst. 1995; 54(2):145-54.
55. Malpas S. Neural Influences on Cardiovascular Variability: Possibilities and Pitfalls. Am J Phsiol Heart Circ Physiol 2002; 282:H6-H20.
56. Moe GK, Rheinboldt WC, Abildshov JA. A computer model of atrialfibrillation. Am Heart J. 1964;67:200 –220.
57. Weiss JN, Qu Z, Chen PS, Lin SF, Karagueuzian HS, Hayashi H, Garfinkel A, Karma A. The dynamics of cardiac fibrillation. Circulation. 2005 23;112(8):1232-40.
58. Chialvo DR, Gilmour RF, Jr., Jalife J. Low dimensional chaos in cardiac tissue. Nature. 1990;343:653-657.
59. Weiss JN, Chen P-S, Qu Z, Karagueuzian HS, Garfinkel A. Ventricular fibrillation : how do we stop the waves from breaking? Circ Res. 2000;87:1103-1107.
60. Davidenko JM: Spiral wave activity: a possible common mechanism for polymorphic and monomorphic ventricular tachycardias. J Cardiovasc Electrophysiol. 1993;4:730-746.
61. Lee M-H, Qu Z, Fishbein GA, Lamp ST, Chang EH, Ohara T, Voroshilovsky O, Kil JR, Hamzei AR, Wang NC, Lin S-F, Weiss JN, Garfinkel A, Karagueuzian HS, Chen P-S: Patterns of wave break during ventricular fibrillation in isolated swine right ventricle. Am J Physiol Heart Circ Physiol. 2001;281:H253-H265.
62. Qu Z, Kil J, Xie F, Garfinkel A, Weiss JN: Scroll wave dynamics in a three-dimensional cardiac tissue model: roles of restitution, thickness, and fiber rotation. Biophys J. 2000;78:2761-2775.
63. Gray RA, Pertsov AM, Jalife J: Spatial and temporal organization during cardiac fibrillation. Nature. 1998;392:75-78.
64. Bray MA, Lin S-F, Aliev RR, Roth BJ, Wikswo JP, Jr.: Experimental and theoretical analysis of phase singularity dynamics in cardiac tissue. J Cardiovasc Electrophysiol. 2001;12:716-722.
65. Valderrabano M, Chen PS, Lin SF. Spatial distribution of phase singularities in ventricular fibrillation. Circulation. 2003;108(3):354-9.
66. Liu YB, Peter A, Lamp ST, Weiss JN, Chen PS, Lin SF. Spatiotemporal correlation between phase singularities and wavebreaks during ventricular fibrillation. J Cardiovasc Electrophysiol. 2003 (10):1103-9.
67. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol. 1998;82:265-271.
68. Thompson CA, Yarzebski J, Goldberg RJ, Lessard D, Gore JM, Dalen JE. Changes over time in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: perspectives from the Worcester Heart Attack Study. Am Heart J. 2000;139:1014-1021.
69. Perina D, Braithwaite S: Acute myocardial infarction in the prehospital setting. Emerg Med Clin North Am. 2001;19:483-492.
70. Taggart P, Sutton PM, Boyett MR, Lab M, Swanton H: Human ventricular action potential duration during short and long cycles. Rapid modulation by ischemia. Circulation. 1996;94:2526-2534.
71. Shaw RM, Rudy Y: Electrophysiologic effects of acute myocardial ischemia: a theoretical study of altered cell excitability and action potential duration. Cardiovasc Res. 1997;35:256-272.
72. Lazzara R, Scherlag BJ: Electrophysiologic basis for arrhythmias in ischemic heart disease. Am J Cardiol. 1984;53:1B-7B.
73. Qu Z, Garfinkel A, Chen P-S, Weiss JN: Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue. Circulation. 2000;102:1664-1670.
74. Garfinkel A, Kim Y-H, Voroshilovsky O, Qu Z, Kil JR, Lee M-H, Karagueuzian HS, Weiss JN, Chen P-S: Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A. 2000;97:6061-6066.
75. Riccio ML, Koller ML, Gilmour RFJ: Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res. 1999;84:955-963.
76. Lee M-H, Lin S-F, Ohara T, Omichi C, Okuyama Y, Chudin E, Garfinkel A, Weiss JN, Karagueuzian HS, Chen P-S: Effects of diacetyl monoxime and cytochalasin D on ventricular fibrillation in swine right ventricles. Am J Physiol Heart Circ Physiol. 2001;280:H2689-H2696.
77. Mandapati R, Asano Y, Baxter WT, Gray R, Davidenko J, Jalife J: Quantification of effects of global ischemia on dynamics of ventricular fibrillation in isolated rabbit heart. Circulation. 1998;98:1688-1696.
78. Wu T-J, Lin S-F, Weiss JN, Ting C-T, Chen P-S: Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution. Circulation. 2002;106:1859-1866.
79. Ideker RE, Rogers JM, Gray RA: Steepness of the restitution curve: a slippery slope? J Cardiovasc Electrophysiol. 2002;13:1173-1175.
80. Banville I, Gray RA: Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol. 2002;13:1141-1149.
81. Mandapati R, Asano Y, Baxter WT, Gray R, Davidenko J, Jalife J. Quantification of effects of global ischemia on dynamics of ventricular fibrillation in isolated rabbit heart. Circulation. 1998;98:1688-1696.
82. Walcott GP, Killingsworth CR, Smith WM, Ideker RE. Biphasic waveform external defibrillation thresholds for spontaneous ventricular fibrillation secondary to acute ischemia. J Am Coll Cardiol. 2002 Jan 16;39(2):359-65.
83. Bers DM. Calcium and cardiac rhythms: physiological and pathophysiological. Circ Res 2002;11;90(1):14-7
84. Schlotthauer K, Bers DM. Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials. Circ Res. 2000;87:774-780.
85. Satoh H, Blatter LA, Bers DM. Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes. : Am J Physiol 1997 Feb;272(2 Pt 2):H657-68.
86. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
87. American Diabetes Association. Diabetes Care 23(suppl 1), 2000.
88. Ganz W. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985;313:1018.
89. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51:5-40.
90. Wu CC, Su MJ, Chi JF, Chen WJ, Hsu HC, Lee YT. The effect of hypercholesterolemia on the sodium inward currents in cardiac myocyte. J Mol Cell Cardiol. 1995;27:1263-1269.
91. Chang C-M, Wu T-J, Zhou S-M, Doshi RN, Lee M-H, Ohara T, Fishbein MC, Karagueuzian HS, Chen P-S, Chen LS. Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation. 2001;103:22-25.
92. Meiri KF, Pfenninger KH, Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones [published erratum appears in Proc Natl Acad Sci U S A 1986 Dec;83(23):9274]. Proc Natl Acad Sci U S A. 1986;83:3537-3541.
93. Lin S-F, Roth BJ, Wikswo JP, Jr. Quatrefoil reentry in myocardium: an optical imaging study of the induction mechanism. J Cardiovasc Electrophysiol. 1999;10:574-586.
94. Wieland DM, Wu JL, Brown LE, Mangner TJ, Swanson DP, Beierwah WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with I-131 iodobenzylguanidine. J Nucl. Med. 1980; 21: 349-353.
95. Merlet P, Valette H, Dubios-Rande J et al. prognosis value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33:471-477.
96. Schofer J, Spielmann R, Schuchert A, Weber K, Schulter M. Iodine-123- metaiodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with iodopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1252-1258.
97. Sisson JC, Shapiro B, Meyer L et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28:1625-1636.
98. Vozzi C, Dupont E, Coppen SR, Yeh HI, Severs NJ. Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol 1999;31:991-1003.
99. Kaprielian RR, Gunning M, Dupont E, Sheppard MN, Rothery SM, Underwood R, Pennell DI, Fox K, Pepper J, Poole-Wilson PA, Severs NJ. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 1998;97:651-660.
100. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R, Halliday D. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech. 2001;52:301-322.
101. Yeh HI, Lai YJ, Lee SH, Lee YN, Ko YS, Chen SA, Severs NJ, Tsai CH. Heterogeneity of myocardial sleeve morphology and gap junctions in canine superior vena cava. Circulation. 2001;104:3152-3157.
102. Yeh HI, Lai YJ, Lee SH, Lee YN, Ko YS, Chen SA, Severs NJ, Tsai CH. Heterogeneity of myocardial sleeve morphology and gap junctions in canine superior vena cava. Circulation. 2001;104:3152-3157.
103. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R, Halliday D. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech. 2001;52:301-322.
104. Koller ML, Riccio ML, Gilmour RF, Jr.: Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am J Physiol. 1998;275: H1635-H1642.
105. Rosenson RS: Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993;22:933-940.
106. Wang TD, Wu CC, Chen WJ et al: Dyslipidemias have a detrimental effect on left ventricular systolic function in patients with a first acute myocardial infarction. Am J Cardiol 1998;81:531-537.
107. Kim D, Duff RA. Regulation of K+ channels in cardiac myocytes by free fatty acids. Circ Res. 1990;67:1040-1046.
108. Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89:6452-6456.
109. Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol. 1975;36:938-953.
110. Fletcher RH, Fletcher SW, Wagner EH. Studying cases . Clinical Epidemiology: The Essentials. Baltimore, MD: Williams & Wilkins, 1996: 208-227.
111. Priori SG, Aliot E, Blomstrom-Lundqvist C et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-1450.
112. Narasimhan C, Dhala A, Axtell K et al. Comparison of outcome of implantable cardioverter defibrillator implantation in patients with severe versus moderately severe left ventricular dysfunction secondary to atherosclerotic coronary artery disease. Am J Cardiol. 1997;80:1305-1308.
113. De Sutter J, Tavernier R, De Buyzere M, Jordaens L, De Backer G. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol. 2000;36:766-772.
114. Nourooz-Zadeh J, Smith CC, Betteridge DJ. Measures of oxidative stress in heterozygous familial hypercholesterolaemia. Atherosclerosis. 2001;156:435-441.
115. Hsu HC, Lee YT, Chen MF. Effects of fish oil and vitamin E on the antioxidant defense system in diet-induced hypercholesterolemic rabbits. Prostaglandins Other Lipid Mediat. 2001;66:99-108.
116. de la Monte SM, Neely TR, Cannon J, Wands JR. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci. 2000;57:1471-1481.
117. Levi-Montalcini R. Growth control of nerve cells by a protein factor and its antiserum. Science. 1964;143:105-110.
118. Rush RA. Immunohistochemical localization of endogenous nerve growth factor. Nature. 1984;312:364-367.
119. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 1987;330:658-659.
120. Guth L. Regeneration in the mammalian peripheral nervous system. Physiol Rev. 1956;36:441-478.
121. Vracko R, Thorning D, Frederickson RG. Fate of nerve fibers in necrotic, healing, and healed rat myocardium. Lab Invest. 1990;63:490-501.
122. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17:525-530.
123. Vancea JE, Campenotb RB, Vancec DE. The synthesis and transport of lipids for axonal growth and nerve regeneration. Biochim Biophys Acta. 2000;1486:84-96.
124. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res. 1992;33:1677-1688.
125. White F, Nicoll JA, Horsburgh K. Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion. Exp Neurol. 2001;169:307-318.
126. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001;294:1354-1357.
127. Chang C-M, Wu T-J, Zhou S-M, Doshi RN, Lee M-H, Ohara T, Fishbein MC, Karagueuzian HS, Chen P-S, Chen LS. Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation. 2001;103:22-25.
128. Zhou S, Cao JM, Tebb ZD, Ohara T, Huang HL, Omichi C, Lee MH, KenKnight BH, Chen LS, Fishbein MC, Karagueuzian HS, Chen P-S. Modulation of QT interval by cardiac sympathetic nerve sprouting and the mechanisms of ventricular arrhythmia in a canine model of sudden cardiac death. J Cardiovasc Electrophysiol. 2001;12:1068-1073.
129. Hassankhani A, Steinhelper ME, Soonpaa MH, Katz EB, Taylor DA, Andrade-Rozental A, Factor SM, Steinberg JJ, Field LJ, Federoff HJ. Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol. 1995;169:309-321.
130. Vatner DE, Asai K, Iwase M, Ishikawa Y, Shannon RP, Homcy CJ, Vatner SF. Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart. Am J Cardiol. 1999;83:80H-85H.
131. Wu CC, Su MJ, Chi JF, Chen WJ, Hsu HC, Lee YT. The effect of hypercholesterolemia on the sodium inward currents in cardiac myocyte. J Mol Cell Cardiol. 1995;27:1263-1269.
132. Karagueuzian HS, Pennec JP, Deroubaix E, de Leiris J, Coraboeuf E. Effects of excess free fatty acids on the electrophysiological properties of ventricular specialized conducting tissue: a comparative study between the sheep and the dog. J Cardiovasc Pharmacol. 1982;4:462-468.
133. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8:690-695.
134. Meiry G, Reisner Y, Feld Y, Goldberg S, Rosen M, Ziv N, Binah O. Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes. J Cardiovasc Electrophysiol. 2001;12:1269-1277.
135. Muzulu SI, Bing RF, Norman RI. Human erythrocyte membrane fluidity and calcium pump activity in primary combined hyperlipidaemia. Clin Sci (Lond). 1995;88:307-310.
136. Charnock JS, McLennan PL, Abeywardena MY. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem. 1992;116:19-25.
137. Kang JX, Leaf A. Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. Proc Natl Acad Sci U S A. 1996;93:3542-3546.
138. Kutryk MJ, Pierce GN. Stimulation of sodium-calcium exchange by cholesterol incorporation into isolated cardiac sarcolemmal vesicles. J Biol Chem. 1988;263:13167-13172.
139. Huang Y, Walker KE, Hanley F, Narula J, Houser SR, Tulenko TN. Cardiac systolic and diastolic dysfunction after a cholesterol-rich diet. Circulation 109:97–102;2004.
140. O'Neill SC, Miller L, Hinch R, Eisner DA. Interplay between SERCA and sarcolemmal Ca2+ efflux pathways controls spontaneous release of Ca2+ from the sarcoplasmic reticulum in rat ventricular myocytes. J Physiol. 2004; 559(Pt 1):121-8.
141. Volders PG, Vos MA, Szabo B, Sipido KR, de Groot SH, Gorgels AP, Wellens HJ, Lazzara R. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res. 2000;46:376-392.
142. Lipp P, Pott L. Transient inward current in guinea-pig atrial myocytes reflects a change of sodium-calcium exchange current.
J Physiol. 1988 Mar;397:601-30.
143. Benndorf K, Biskup C, Friedrich M. Voltage-dependent kinetics of Na-Ca exchange current in Ca(2+)-loaded guinea pig heart cells.
Am J Physiol. 1993 Nov;265(5 Pt 1):C1258-65.
144. Schillinger W, Schneider H, Minami K, Ferrari R, Hasenfuss G. Importance of sympathetic activation for the expression of Na+-Ca2+-exchanger in end-stage failing human myocardium. Eur Heart J 23:1118–1124;2002.
145. van Veen TAB, van Rijen HVM, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 2001;51:217-229.
146. Oyamada M, Kimura H, Oyamada Y, Miyamoto A, Ohshika H, Mori M. The expression, phosphorylation, and localization of connexin 43 and gap-junctional intercellular communication during the establishment of a synchronized contraction of cultured neonatal rat cardiac myocytes. Exp Cell Res 1994;212:351-358.
147. Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 2001;51:681-690.
148. Zeevi-Levin N, Barac YD, Reisner Y, Reiter I, Yaniv G, Meiry G, Abassi Z, Kostin S, Schaper J, Rosen MR, Resnick N, Binah O. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res 2005;66:64-73.
149. Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI, Gutstein DE. Modulation of cardiac gap junction expression and arrhythmic susceptibility.
Circ Res. 2004 Nov 12;95(10):1035-41.
150. van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K, Jongsma HJ, Opthof T, de Bakker JM. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 2004;109:1048-1055.
151. Bastiaanse EM, Jongsma HJ, van der Laarse A, Takens-Kwak BR. Heptanol-induced decrease in cardiac gap junctional conductance is mediated by a decrease in the fluidity of membranous cholesterol-rich domains. J Membr Biol 1993;136:135-145.
152. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T. Gap junction alterations in human cardiac disease. Cardiovasc Res 2004;62:368-377.
153. Severs NJ, Dupont E, Coppen SR, et al. Remodeling of gap junctions and connexin expression in heart disease. Biochim Biophys Acta 2004;1662:138-148.
154. Malewicz B, Kumar VV, Johnson RG, Baumann WJ. Lipids in gap junction assembly and function. Lipids. 1990;25:419-427.
155. Meyer RA, Lampe PD, Malewicz B, Baumann WJ, Johnson RG. Enhanced gap junction formation with LDL and apolipoprotein B. Exp Cell Res 1991;196:72-81.
156. Henry PD, Pacifico A. Altering molecular mechanisms to prevent sudden arrhythmic death. Lancet 1998;351:1276-1278.
157. Kinscherf R, Kamencic H, Deigner HP, Metz J. Hypercholesterolemia-induced long-term increase of macrophages in the myocardium of New Zealand White rabbits. Cells Tissues Organs 2003;174:184-193.
158. Petrich BG, Gong X, Lerner DL, Wang X, Brown JH, Saffitz JE, et al. c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res 2002;91:640-647.
159. Shyu KG, Wang BW, Yang YH, Tsai SC, Lin S, Lee CC. Amphetamine activates connexin43 gene expression in cultured neonatal rat cardiomyocytes through JNK and AP-1 pathway. Cardiovasc Res 2004;63:98-108.
160. Hume JR, Harvey RD: Chloride conductance pathways in heart. Am J Physiol 1991;261:C399-C412.
161. Takei M, Sasaki Y, Yonezawa T, Lakhe M, Aruga M, Kiyosawa K: The autonomic control of the transmural dispersion of ventricular repolarization in anesthetized dogs. J Cardiovasc Electrophysiol 1999;10:981-989.
162. Shimizu W, Antzelevitch C: Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998;98:2314-2322.
163. Antzelevitch C: Sympathetic modulation of the long QT syndrome. Eur.Heart J. 2002;23:1246-1252.
164. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT: Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996;384:80-83.
165. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G: K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996;384:78-80.
166. Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L: Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999;34:823-829.
167. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U: Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation 1991;84:503-511.
168. Kadish AH, Weisman HF, Veltri EP, Epstein AE, Slepian MJ, Levine JH: Paradoxical effects of exercise on the QT interval in patients with polymorphic ventricular tachycardia receiving type Ia antiarrhythmic agents. Circulation 1990;81:14-19.
169. Shimizu W, Antzelevitch C: Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000;35:778-786.
170. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK: Assessment of QT Interval and QT Dispersion for Prediction of All-Cause and Cardiovascular Mortality in American Indians : The Strong Heart Study. Circulation 2000;101:61-66.
171. Wolk R, Cobbe SM, Hicks MN, Kane KA. Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy. Pharmacol Ther. 1999;84:207-231.
172. Amlie JP. Dispersion of repolarization. A basic electrophysiological mechanism behind malignant arrhythmias. Eur Heart J. 1997;18:1200-1202.
173. Salama G, Kanai AJ, Huang D, Efimov IR, Girouard SD, Rosenbaum DS. Hypoxia and hypothermia enhance spatial heterogeneities of repolarization in guinea pig hearts: analysis of spatial autocorrelation of optically recorded action potential durations. J Cardiovasc Electrophysiol. 1998;9:164-183.
174. Yoshioka K, Gao DW, Chin M, Stillson C, Penades E, Lesh M, O'Connell W, Dae M. Heterogeneous sympathetic innervation influences local myocardial repolarization in normally perfused rabbit hearts. Circulation. 2000;101:1060-1066.
175. Spear JF, Moore EN. Modulation of arrhythmias by isoproterenol in a rabbit heart model of d-sotalol-induced long Q-T intervals. Am J Physiol Heart Circ Physiol. 2000;279:H15-H25.
176. Volders PG, Vos MA, Szabo B, Sipido KR, de Groot SH, Gorgels AP, Wellens HJ, Lazzara R. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res. 2000;46:376-392.
177. Banville I, Gray RA. Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol. 2002;13:1141-1149.
178. Xie F, Qu Z, Garfinkel A, Weiss JN: Effects of simulated ischemia on spiral wave stability. Am J Physiol Heart Circ Physiol. 2001;280:H1667-H1673.
179. Cao J-M, Qu Z, Kim Y-H, Wu T-J, Garfinkel A, Weiss JN, Karagueuzian HS, Chen P-S: Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res. 1999;84:1318-1331.
180. Banville I, Gray RA: Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol. 2002;13:1141-1149.
181. Pinto JM, Boyden PA: Electrical remodeling in ischemia and infarction. Cardiovasc Res. 1999;42:284-297.
182. Horner SM, Dick DJ, Murphy CF, Lab MJ: Cycle length dependence of the electrophysiological effects of increased load on the myocardium. Circulation. 1996;94:1131-1136.
183. Rankovic V, Patel N, Jain S, Robinson N, Goldberger J, Horvath G, Kadish A: Characteristics of ischemic and peri-ischemic regions during ventricular fibrillation in the canine heart. J Cardiovasc Electrophysiol. 1999;10:1090-1100.
184. Zaitsev AV, Guha PK, Sarmast F, Kolli A, Berenfeld O, Pertsov AM, De Groot JR, Coronel R, Jalife J: Wavebreak formation during ventricular fibrillation in the isolated, regionally ischemic pig heart. Circ Res. 2003.
185. Chen PS, Wu TJ, Ting CT, Karagueuzian HS, Garfinkel A, Lin SF, Weiss JN: A tale of two fibrillations. Circulation. 2003;108:2298-2303.
186. Weisfeldt ML, Becker LB: Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA. 2002;288:3035-3038.
187. Hao Qin, Gregory P. Walcott, Cheryl R. Killingsworth, Dennis L. Rollins, William M. Smith, and Raymond E. Ideker. Impact of Myocardial Ischemia and Reperfusion on Ventricular Defibrillation Patterns, Energy Requirements, and Detection of Recovery. Circulation 2002 105: 2537 - 2542
188. Lee M-H, Lin S-F, Ohara T, Omichi C, Okuyama Y, Chudin E, Garfinkel A, Weiss JN, Karagueuzian HS, Chen P-S: Effects of diacetyl monoxime and cytochalasin D on ventricular fibrillation in swine right ventricles. Am J Physiol Heart Circ Physiol. 2001;280:H2689-H2696.
189. Hayashi H, Miyauchi Y, Chou CC, Karagueuzian HS, Chen PS, Lin SF: Effects of Cytochalasin D on Electrical Restitution and the Dynamics of Ventricular Fibrillation in Isolated Rabbit Heart. J Cardiovasc Electrophysiol. 2003;14:1077-1084.
190. Verrier RL, Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. Curr Opin Cardiol. 2004; 19(1):2-11. | en |